These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23143394)

  • 1. Liquid formulations for stabilizing IgMs during physical stress and long-term storage.
    Mueller M; Loh MQ; Tscheliessnig R; Tee DH; Tan E; Bardor M; Jungbauer A
    Pharm Res; 2013 Mar; 30(3):735-50. PubMed ID: 23143394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid formulations for long-term storage of monoclonal IgGs.
    Mueller M; Loh MQ; Tee DH; Yang Y; Jungbauer A
    Appl Biochem Biotechnol; 2013 Feb; 169(4):1431-48. PubMed ID: 23315232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    PDA J Pharm Sci Technol; 2012; 66(3):221-35. PubMed ID: 22634588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation.
    Davis JM; Zhang N; Payne RW; Murphy BM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC
    Pharm Dev Technol; 2013; 18(4):883-96. PubMed ID: 22813478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    J Pharm Sci; 2020 Jan; 109(1):807-817. PubMed ID: 31622600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
    Lueckel B; Helk B; Bodmer D; Leuenberger H
    Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of bulking agents on the stability of a lyophilized monoclonal antibody.
    Meyer JD; Nayar R; Manning MC
    Eur J Pharm Sci; 2009 Aug; 38(1):29-38. PubMed ID: 19467324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
    Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
    Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.
    Manikwar P; Majumdar R; Hickey JM; Thakkar SV; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2013 Jul; 102(7):2136-51. PubMed ID: 23620222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorbitol crystallization can lead to protein aggregation in frozen protein formulations.
    Piedmonte DM; Summers C; McAuley A; Karamujic L; Ratnaswamy G
    Pharm Res; 2007 Jan; 24(1):136-46. PubMed ID: 17109212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody.
    Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT
    J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse Proteolysis: An Orthogonal Tool for Protein Formulation Screening.
    Iyer LK; Phanse R; Xu M; Lan W; Krause ME; Bolgar M; Hart S
    J Pharm Sci; 2019 Feb; 108(2):842-850. PubMed ID: 30257193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying.
    Park J; Nagapudi K; Vergara C; Ramachander R; Laurence JS; Krishnan S
    Pharm Res; 2013 Apr; 30(4):968-84. PubMed ID: 23184227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
    Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
    J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.